🔎 Trials Near Me

Akèy › Osteyosakòm › Missouri › St. Louis

Etid klinik pou Osteyosakòm nan St. Louis, MO

10 etid pou Osteyosakòm ap chèche patisipan nan sit nan ak bò kote St. Louis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

Ap rekriteFaz 2
  • Washington University School of Medicine, St Louis
Laj 12 a 39 · Tout sèks · Mizajou Sep 29, 2026 · NCT04616560

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Ap rekriteFaz 1/2
  • Cardinal Glennon Children's Medical Center, St Louis
Jiska laj 26 · Tout sèks · Mizajou Sep 3, 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Ap rekriteFaz 1/2
  • Cardinal Glennon Children's Medical Center, St Louis
Jiska laj 30 · Tout sèks · Mizajou Sep 3, 2026 · NCT06541262

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

Ap rekriteFaz 1/2
  • Washington University in St. Louis, St Louis
Laj 12 a 40 · Tout sèks · Mizajou Sep 3, 2026 · NCT07725380

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Ap rekriteFaz 3
  • Cardinal Glennon Children's Medical Center, St Louis
  • Washington University School of Medicine, St Louis
  • Mercy Hospital Saint Louis, St Louis
Jiska laj 50 · Tout sèks · Mizajou Aug 25, 2026 · NCT05235165

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Washington University School of Medicine, St Louis
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

Ap rekriteFaz 1/2
  • Washington University, St Louis
Laj 2 a 21 · Tout sèks · Mizajou Aug 11, 2026 · NCT05642455

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Ap rekriteFaz 1/2
  • Washington University Medical Center, St Louis
Jiska laj 30 · Tout sèks · Mizajou Aug 3, 2026 · NCT06239272

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Ap rekriteFaz 2
  • Washington University in St. Louis, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT04040205

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Ap rekriteEtid obsèvasyon
  • Washington University School of Medicine, St Louis
Tout laj · Tout sèks · Mizajou May 18, 2026 · NCT01790152

Etid Osteyosakòm nan lòt vil

Lòt etid nan St. Louis

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.